Diagnosis and Treatment of Conn Syndrome: A Case Study

Authors

Muhammad Syah Abdaly, Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia, RSUPN dr. Cipto Mangunkusumo
Juliyanti Juliyanti, Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia, RSUPN dr. Cipto Mangunkusumo
Maruhum Bonar Marbun, Divisi Ginjal Hipertensi, Departemen Ilmu Penyakit Dalam, Fakultas Kedokteran Universitas Indonesia, RSUPN dr. Cipto MangunkusumoFollow

Abstract

Acute neuromuscular disorder is a commonly found medical condition, which may prove to be fatal in certain conditions. Hypokalemia is one possible cause of neuromuscular disorder. In patient with hypokalemia accompanied with hypertension, primary hyperaldosteronism might be the primary cause. Primary hyperaldosteronism (Conn syndrome) is clinically known as a triad, which is consists of hypertension, hypokalemia, and metabolic alkalosis. In this article, the case of a patient with neuromuscular disorder is presented, and after evaluation, it was found that the patient was suffered from the Conn syndrome

References

1. Singer GG, Brenner BM. Fluid and electrolyte disturbances. In: Fauci AS, editor. Harrison’s principles of internal medicine. 17th edition. New York: McGrawHill; 2008. p.282-5. 2. Kasifoglu T, Akalin K, Cansu DU, Korkmaz C. Hypokalemic paralysis due to primary hyperaldosteronism simulating Gitelman’s syndrome. Saudi J Kidney Dis Transpl. 2009;20(2):285-7. 3. Chen J. Conn’s Syndrome. In: Henderson KE et al, editors. The Washington Manual Endocrinology Subspecialty Consult. USA: Lippincott Williams & Wilkins; 2006. p.71-5. 4. Williams JS, Williams GH, Raji A, Jeunemaitre X, Brown NJ, Hopkins PN, et al. Prevalence of primary hyperaldosteronism in mild to moderate hypertension without hypokalaemia. J Hum Hypertens. 2005;20:129-36. 5. Rose BD, Sterns RH, Post TW. Pathogenesis of metabolic alkalosis. Alphen aan den Rijn, The Netherlands: UpToDate; 2010. 6. Mattsson C, Young WF. Primary aldosteronism: diagnostic and treatment strategies. Nat Clin Pract Neph. 2006;2:198-208. 7. Seccia TM, Fassina A, Nussdorfer GG, Pessina AC, Rossi GP. Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn’s syndrome with an ominous clinical course. Endocr Relat Cancer. 2005;12:149-59. 8. Funder JW, Carey RM, Fardella C, Gomez-Sanchez CE, Mantero F, Stowasser M, et al. Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2008;93:3266-81. 9. Stowasser M, Gordon RD, Gunasekera TG, Cowley DC, Ward G, Archibald C, et al. High rate of detection of primary aldosteronism, including surgically treatable forms, after ‘non-selective’ screening of hypertensive patients. J Hypertens. 2003;21:2149-57. 10. Kuo CC, Wu VC, Huang KH, Wang SM, Chang CC, Lu CC, et al.Verification and evaluation of aldosteronism demographics in the Taiwan Primary Aldosteronism Investigation Group (TAIPAI Group). J Renin Angiotensin Aldosterone Syst. 2011;12:348-57. 11. Sawka Am, Young WF, Thompson GB, et al. Primary Aldosteronism: Factors Associated with Normalization of Blood Pressure after Surgery. Ann Intern Med. 2001;135:258-61.

Recommended Citation

Abdaly, Muhammad Syah; Juliyanti, Juliyanti; and Marbun, Maruhum Bonar (2017) "Diagnosis and Treatment of Conn Syndrome: A Case Study," Jurnal Penyakit Dalam Indonesia: Vol. 4: Iss. 3, Article 8.
DOI: 10.7454/jpdi.v4i3.136
Available at: https://scholarhub.ui.ac.id/jpdi/vol4/iss3/8